Showing results (461-470 of 5,003) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|January 21, 2017
Totally Implantable Venous Access Devices: A Review of Complications and Management StrategiesOmidreza Tabatabaie, Gyulnara G Kasumova, Mariam F Eskander, et al.American Journal of Clinical Oncology|April 2, 2004
Adjuvant high-dose rate brachytherapy after chemoradiation for treatment of early T-stage nasopharyngeal carcinomaJiade J Lu, Thomas Shakespeare, Boon Cher Goh, et al.American Journal of Clinical Oncology|February 6, 2004
Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicityYvonne Hsu, Anil K Sood, Joel I SoroskyAmerican Journal of Clinical Oncology|February 6, 2004
Sinonasal teratocarcinosarcomaK Kenneth Chao, Tony Y Eng, Jonathan Barnes, et al.American Journal of Clinical Oncology|February 6, 2004
Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancerJuan J González-Aguilera, Soledad Oliart, Mariano Moreno Azcoita, et al.American Journal of Clinical Oncology|February 6, 2004
Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experienceFrancisco J Hernandez-Ilizaliturri, Dongfeng Tan, David Cipolla, et al.American Journal of Clinical Oncology|February 6, 2004
Pattern of proliferative index (Ki-67) after anti-androgen manipulation reflects the ability of irradiation to control prostate cancerBrace L Hintz, Charles Koo, James F MurphyAmerican Journal of Clinical Oncology|February 6, 2004
Squamous cell carcinoma arising in a second branchial cleft cystMichael R Girvigian, Aida K Rechdouni, Gary D Zeger, et al.American Journal of Clinical Oncology|December 1, 1992
Radiation therapy in the treatment of pituitary adenomasD J Salinger, L W Brady, C T MiyamotoAmerican Journal of Clinical Oncology|December 1, 1992
Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute lymphoblastic leukemia. A randomized phase II trial from the Childrens Cancer Study GroupJ S Miser, J Roloff, J Blatt, et al.Pageof 501